Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Organocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104558014A reveals a novel 3,4-dihydroisoquinoline NHC catalyst enabling high enantioselectivity in naphthopyrone manufacturing with simplified purification.
Patent CN103415501A details stable iodoarene derivatives for high-ee spirolactone production. Enables cost reduction in pharma intermediate manufacturing with scalable catalytic routes.
Novel catalytic route for trifluoromethyl spiro oxindoles offering high stereoselectivity and simplified purification for pharmaceutical intermediate manufacturing.
Patent CN102190592B reveals a novel NHC-catalyzed route for DMF, eliminating salt blockages and ensuring continuous production for reliable supply chains.
Novel thiourea-catalyzed asymmetric synthesis of trifluoromethyl bisoxazoles with high ee. Ideal for anticancer drug development and cost-effective API manufacturing.
Patent CN114436912A reveals a cinchona-catalyzed route for carbon-nitrogen axis chiral sulfonamides. Achieves high enantioselectivity and yield under mild conditions for cost-effective manufacturing.
Patent CN101041638B reveals novel metal-free chiral amines. Discover cost-effective synthesis and high-purity supply for asymmetric catalysis applications.
Patent CN105906649B details asymmetric synthesis of chiral spirolides. Offers high stereoselectivity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Novel chiral catalytic route for tenofovir analogs offering high enantioselectivity and cost efficiency for global pharmaceutical supply chains and manufacturing partners.
Patent CN109942553B discloses a one-step asymmetric synthesis of chiral 3,4,6-trisubstituted tetrahydro-2H-pyran-2-ones using chiral secondary amine catalysts, offering high enantioselectivity and operational simplicity for pharmaceutical manufacturing.
Patent CN110066244B reveals a high-yield method for chiral tetrahydroquinoline synthesis using saturated aldehydes, offering >99% ee and significant cost reduction potential.
Patent CN101314559B details a low-cost kinetic resolution method for aromatic chiral secondary alcohols using Boc-Proline, offering high purity for pharma intermediates.
Patent CN113444108B reveals a novel organocatalytic route for 1,4-sulfur bridge polycyclic compounds, offering high stereoselectivity and mild conditions for API manufacturing.
Discover the novel synthesis of chiral binaphthyl-aza ligands from patent CN112142638A. Achieve high enantioselectivity with scalable, cost-effective manufacturing processes.
Novel organocatalytic route for bicyclic proline esters. Enhances purity and scalability for API manufacturing. Cost-effective intermediate production.
Novel quinine-catalyzed route for chiral sulfinamides. High purity, mild conditions, scalable for pharma intermediates. Reliable supply chain solutions.
Patent CN112266364B reveals metal-free hydrogenation for tetrahydroquinoxaline. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing without transition metals.
Patent CN111763157B reveals a novel one-step asymmetric synthesis for chiral amino compounds, enabling cost reduction in pharmaceutical manufacturing and safer scale-up.
Novel tertiary amine-thiourea catalyst enables high-yield asymmetric conjugate addition for scalable API intermediate production with superior enantioselectivity.
Patent CN103189352A reveals a novel organocatalytic Mannich reaction for high-purity pharmaceutical intermediates, offering significant cost reduction and scalable supply chain solutions.